We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




First-in-Human Implant of Thought-Driven Movement Device to Treat Spinal Cord Injury

By HospiMedica International staff writers
Posted on 28 Sep 2023
Print article
Image: The ARC-IM Stimulator with brain-computer interface restores arm, hand, and finger function after spinal cord injury (Photo courtesy of ONWARD Medical)
Image: The ARC-IM Stimulator with brain-computer interface restores arm, hand, and finger function after spinal cord injury (Photo courtesy of ONWARD Medical)

In order to walk, signals from the brain are sent to neurons in the lumbosacral part of the spinal cord. When a spinal cord injury occurs, it cuts off this essential communication between the brain and the area of the spinal cord responsible for walking, leading to paralysis. Even if the neurons themselves aren't directly damaged, the disruption of the descending pathways breaks the chain of commands needed for these neurons to enable walking. Now, in a pioneering procedure, physicians have paired an implantable spinal cord stimulator with a brain-computer interface (BCI) to restore arm, hand, and finger function in patients with spinal cord injury.

ONWARD Medical (Eindhoven, The Netherlands) has announced the first-in-human implant of its investigational ARC-IM implantable spinal cord stimulator, to restore upper extremity function after spinal cord injury. Along with the implant, the patient was equipped with an investigational BCI, designed to enable thought-controlled movements when used in conjunction with ARC-IM. ARC-IM administers specific, pre-programmed therapy directly to the spinal cord to revive movement and other functionalities after a spinal cord injury. Previously tested for its potential to restore mobility and stabilize blood pressure, ARC-IM Therapy is now, for the first time, being used to help spinal cord injury patients regain upper limb movement and function.

In conjunction with the ARC-IM implant, the BCI is designed to identify a paralyzed individual's intent to move their upper limbs. The BCI employs artificial intelligence to interpret these thoughts, which ARC-IM then transforms into targeted spinal cord stimulation, enabling movement driven by thought alone. This advancement is part of a continuing clinical trial exploring the safety and efficacy of using thought to stimulate the spinal cord after an injury. The innovation builds upon ONWARD's May 2023 announcement that combining ARC Therapy with a BCI implant allowed a person to achieve enhanced control over his paralyzed legs. Further details about this groundbreaking research are expected to be released in the near future, along with a scientific paper detailing the procedure and its outcomes.

“We are excited to learn how ARC-IM Therapy may restore upper extremity function after SCI, and we are eager to see how the addition of a BCI might augment our therapy,” said Dave Marver, CEO of ONWARD.

Related Links:
ONWARD Medical 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
3T MRI Scanner
MAGNETOM Cima.X
New
Infant Phototherapy Unit
TRP100

Print article

Channels

Critical Care

view channel
Image: AI could tackle the huge problem of antimicrobial resistance in intensive care (Photo courtesy of 123RF)

AI Provides Same-Day Prediction of Bloodstream Infection and Antimicrobial Resistance in ICU Patients

Antimicrobial resistance, which refers to the ability of microorganisms to develop defenses against treatments, presents a significant challenge to global healthcare. Infections in the bloodstream can... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.